The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...
Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...
The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The other facility will be in Neuville-sur-Saône, France. SINGAPORE ...
The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The other facility will be in Neuville-sur-Saône, France. SINGAPORE ...